期刊文献+

肝X受体上调糖尿病小鼠肾脏脂肪酸合成酶的表达

Activation of liver X receptor upregulates fatty acid synthase expression in diabetic kidney
原文传递
导出
摘要 目的探讨肝X受体(liver X receptor,LXR)对糖尿病小鼠肾脏脂肪酸合成酶(fatty acid synthase,FAS)表达的影响及可能机制。方法在体研究部分:糖尿病db/db小鼠和对照的db/m小鼠分别予以LXR激动剂T0901317(3mg·kg^-1·d^-1)灌胃处理7d,采用免疫组织化学、实时荧光定量PCR、蛋白印迹法检测FAS和活化型固醇调节元件结合蛋白(sterol regulatory element—binding protein-1,SREBP-1)的表达水平。离体研究部分:T0901317(10μmol/L)刺激小鼠近曲小管上皮细胞系(MCT细胞)24h,或转染SREBP-1c表达质粒。LXR或SREBP-1c表达质粒转染人胚。肾细胞系(HEK293细胞)12h,分别采用实时荧光定量PCR、转染荧光素酶报告基因等方法,检测FAS表达和FAS启动子活性水平。结果免疫组化结果显示FAS蛋白主要表达在肾皮质,肾小球表达量较少。同对照组db/m小鼠相比.db/db小鼠肾脏FASmRNA和蛋白水平均明显降低(P〈0.05);T0901317处理可使db/db小鼠。肾脏FASmRNA表达升高1.3倍(P〈0.01);db/m小鼠肾脏SREBP-1的mRNA升高5.1倍(P〈0.01),db/db小鼠肾脏SREBP.1的mRNA升高17倍(P〈0.01);T0901317也能上调MeT细胞FAS的mRNA表达水平,升高1.5倍(P〈0.05);过表达SREBP-1c也可使MCT细胞中FASmRNA的表达量增加1.8倍(P〈0.05):不仅如此,LXR的激活、过表达LXR或SREBP-1c能增加HEK293细胞FAS基因启动子活性(P〈0.01)。结论LXR能够通过其本身的直接作用和SREBP-1c的间接作用上调肾脏FAS的表达,LXR可能介导了糖尿病肾脏的脂质代谢紊乱过程。 Objective To investigate the effect and mechanism of liver X receptor ( LXR ) agonist on expression of fatty acid synthase (FAS) in diabetic kidney. Methods In the part of in vivo study, immanostaining was used to detect the FAS protein expression in kidney. 16-week-old male db/db mice on C57BL/6 background were administered via gavage a LXR synthetic agonist, TO901317, at a dose of 3 mg·kg^-1·d^-1 or vehicle (0. 5% Carboxymethyl Cellulose Sodium, CMC-Na)alone for 7 d; Quantitative RT-PCR and Western blot were used to detect mRNA and protein levels of FAS and SREBP-1. In the part of in vitro study, MCT cell ( a mouse murine proximal tubule cell line ) was treated with l0 txmol/L TO901317 for 24 h or transfected with active SREBP-1 c expression vector (SREBP-lcN). HEK293 cells( a human renal tubule cell line) were transfected with mFAS-( 1.7 kb) -luc, LXR expression vector or SREBP-lcN for 12 h. Quantitative RT-PCR and luciferase reproter assay were utilized to examine FAS mRNA level and FAS promoter activity. Results FAS was abundantly expressed in renal cortex, with low expresson in renal glomeruli. Tbe mRNA and protein expressious of FAS in kidney of db/db mice were lowered compared with db/m mice. TO90137 treatment increased FAS mRNA expression by 1.3-fold. TO901317 increased expression of SREBP-1 in kidneys of db/m and db/db mice by 5.1-fold and 17-fold, respectively. TO901317 and overexpression of SREBP-lc increased expression of FAS in MCT cells by 1.5-fold and 1.8-h)ld. Transcription activity of FAS were induced by TO901317, LXR, and SREBP-lcN overexpressions in HEK293 cells. Conclusions Both direct ( LXRE ) and indirect ( SREBP-1 c ) mechanisms may contribute to the up-regulation of FAS expression by LXR in renal proximal tubule cells.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2016年第1期56-61,共6页 Chinese Journal of Endocrinology and Metabolism
关键词 肝X受体 固醇调节元件结合蛋白 脂肪酸合成酶 糖尿病 2型 Liver X receptor Sterol regulatory element-binding protein-1c Fatty acid synthase Diabetesmellitus, type 2
  • 相关文献

参考文献16

  • 1Pugliese G. Updating the natural history of diabetic nephropathy[J]. Acta Diabetologica, 2014,51(6):905-915.
  • 2Hirano T. Abnormal lipoprotein metabolism in diabetic nephropathy[J]. Clin Exp Nephrol, 2014,18(2):206-209.
  • 3Hao J, Liu SX, Zhao S, et al. High-fat diet causes increased serum insulin and glucose which synergistically lead to renal tubular lipid deposition and extracellular matrix accumulation[J]. Br J Nutr, 2012,107(1):74-85.
  • 4Wang Z, Jiang T, Li J, et al. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes[J]. Diabetes, 2005,54(8):2328-2335.
  • 5Proctor G, Jiang T, Iwahashi M, et al. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes[J]. Diabetes, 2006,55(9):2502-2509.
  • 6Kim YS, Jung DH, Sohn E, et al. Glycoxidised LDL induced the upregulation of Axl receptor tyrosine kinase and its ligand in mouse mesangial cells[J]. PLoS One, 2012,7(11):e50297.
  • 7Laffitte BA, Chao LC, Li J, et al. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue[J]. Proc Nat Acad Sci USA, 2003,100(9):5419-5424.
  • 8Wu J, Zhang Y, Wang N, et al. Liver X receptor-alpha mediates cholesterol efflux in glomerular mesangial cells[J]. Am J Physiol, 2004,287(5):F886-F895.
  • 9Sun L, Halaihel N, Zhang W, et al. Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus[J]. J Biol Chem, 2002,277(21):18919-18927.
  • 10Yoshikawa T, Shimano H, Amemiya-Kudo M, et al. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter[J]. Mol Cell Biol, 2001,21(9):2991-3000.

二级参考文献20

  • 1Cao G, Liang Y, Broderick CL, et aL Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis. J Biol Chem, 2003,278 : 1131-1136.
  • 2Laffitte BA, Chao LC, Li J, et al. Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc Natl Acad Sci U S A, 2003,100:5419-5424.
  • 3Wu J, Zhang Y, Wang N, et aL Liver X receptor-alpha mediates cholesterol efflux in glomendar mesangial cells. Am J Physiol Renal Physiol, 2004,287 : F886-895.
  • 4Kennedy MA, Venkateswaran A, Tarr PT, et al. Characterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the protein. J Biol Chem, 2001,276:39438-39447.
  • 5Repa JJ, Berge KE, Pomajzl C, et al. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem, 2002,277:18793-18800.
  • 6Laffitte BA, Repa JJ, Joseph SB, et al. LXRs control lipidinducible expression of the apolipoprotein E gene in macrophages and adipocytes. Prec Nail Acad Sci U S A, 2001 , 98 : 507-512.
  • 7Luo Y, Tall AR. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J Clin Invest, 2000,105:513-520.
  • 8Edwards PA, Kast HR, Anisfeld AM. BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis. J Lipid Res, 2002,43:2-12.
  • 9Schultz JR, Tu H, Luk A, et al.Role of LXRs in control of lipogenesis. Genes Dev, 2000,14:2831-2838.
  • 10Zhang Y, Zhang X, Chen L, et al. Liver X receptor agonist TO- 901317 upregulates SCD1 expression in renal proximal straight tubule. Am J Physiol Renal Physiol, 2006,290 : F1065-1073.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部